Premium
Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma
Author(s) -
Kwong Dora L. W.,
Wei William I.,
Cheng Ashley C. K.,
Choy Damon T. K.,
Lo Anthony T. C.,
Wu P. M.,
Sham Jonathan S. T.
Publication year - 2001
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(20010315)91:6<1105::aid-cncr1106>3.0.co;2-z
Subject(s) - medicine , brachytherapy , nasopharyngeal carcinoma , biopsy , surgery , carcinoma , radiation therapy , lesion , survival rate , gastroenterology
Abstract BACKGROUND Brachytherapy is useful for the reirradiation of nasopharyngeal carcinoma. In the current study, the long term treatment results of permanent radioactive gold 198 grain interstitial implantation in patients with persistent and recurrent nasopharyngeal carcinoma were reviewed. METHODS Gold grain implantation was performed under direct vision with a split palate approach to provide 60 grays (Gy) 0.5 cm away from the plane of implantation. Between August 1986 and May 1999, 106 patients were treated with gold grain implantation (45 patients for persistent disease, 53 patients for first recurrence, and 8 patients for second recurrence in the nasopharynx). All patients had histologically proven disease by biopsy before undergoing implantation. RESULTS Patients with persistent disease and those with first recurrence did well with the gold grain implantation. The 5‐year local control rates for patients with persistent disease, first recurrence, and second recurrence in the nasopharynx were 87.2%, 62.7%, and 23.4%, respectively ( P = 0.0004). The 5‐year metastasis free survival rates were 68.1%, 60.3%, and 40%, respectively, for the 3 groups ( P = 0.048). The overall survival rates at 5 years for the 3 groups were 79.1%, 53.6%, and 42.9%, respectively ( P = 0.0047). Patients with computed tomography evidence of disease extension outside the nasopharynx had a lower local control rate compared with patients whose disease was confined to the nasopharynx (5‐year local control rate of 52% vs. 72.3%; P = 0.031). The size of the lesion was not found to be an independent prognostic factor for local control after implantation. Multivariate analysis showed only an indication for implantation (persistent disease, first recurrence, and second recurrence) to be a significant prognostic factor for local control. Complications attributed to gold grain implantation included headache, palatal fistula, and mucosal radiation necrosis at the site of implantation, and were reported to occur in 28.3%, 18.9%, and 16%, respectively, of patients. CONCLUSIONS For selected patients with disease confined to the nasopharynx, gold grain implantation is an effective salvage treatment for persistent and recurrent nasopharyngeal carcinoma. Cancer 2001;91:1105–13. © 2001 American Cancer Society.